Monoclonal Antibodies Redefine Animal Osteoarthritis Treatment
The Veterinary Pain Management drugs market is forecast to grow from approximately USD 2.5 billion in 2024 to USD 3.82 billion by 2030, registering a steady CAGR of 6.8%. The growth is fueled by increasing pet ownership, a rise in chronic conditions like osteoarthritis and cancer among animals, greater adoption of pet insurance, and the launch of advanced treatment options including monoclonal antibodies and laser therapy. To Get Free Sample Report: https://www.datamintelligence.com/download-sample/veterinary-pain-management-market Key Market Drivers 1. Rise in Pet Ownership and Animal Welfare Awareness Globally, pet ownership is increasing rapidly, especially in North America and parts of Asia. More pet owners are seeking quality veterinary care, driving demand for effective pain management solutions. Humanization of pets has led to increased spending on diagnostics, therapeutics, and long-term care. 2. Chronic Conditions in Companion Animals Diseases such as osteoarthritis, ...